Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H13NO2S |
| Molecular Weight | 271.334 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=CC=CC=C2SC3=CC=C(CC(O)=O)C=C13
InChI
InChIKey=LMINNBXUMGNKMM-UHFFFAOYSA-N
InChI=1S/C15H13NO2S/c1-16-11-4-2-3-5-13(11)19-14-7-6-10(8-12(14)16)9-15(17)18/h2-8H,9H2,1H3,(H,17,18)
| Molecular Formula | C15H13NO2S |
| Molecular Weight | 271.334 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0090331 Sources: http://www.ncbi.nlm.nih.gov/pubmed/6318340 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: DOI: 10.1177/030006057200100106 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
1.5 g per day for a week
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6317211
50 uM to protect bacteriophage T2 from inactivation by the model peroxy radical CCl3O2
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:57 GMT 2025
by
admin
on
Mon Mar 31 17:55:57 GMT 2025
|
| Record UNII |
12I0HHE2ZY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4164
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
C166452
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
m7485
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
237-795-0
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
DTXSID7023308
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
31838
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
13993-65-2
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
100000080911
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105269
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
1776
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
12I0HHE2ZY
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
SUB08883MIG
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
2519
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY | |||
|
C100259
Created by
admin on Mon Mar 31 17:55:57 GMT 2025 , Edited by admin on Mon Mar 31 17:55:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |